Under construction – not a live service
Sign in
Enrolling by invitationPhase 1/2

Self-acupuncture study for people with migraines

Tests whether adults with migraines can learn to give themselves acupuncture.

Plain-language title generated from the registry record
Registry title: Self-acupuncture for Migraines Feasibility Study

Key facts

Where
London, United KingdomSee the site
Phase
Phase 1/2

Where in United Kingdom

  • Royal London Hospital for Integrated MedicineLondon, United KingdomNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of West London
Trial code
NCT06716944
Record updated
4 December 2024
Original description
Patients who have had a course of acupuncture at the Royal London Hospital for Integrated Medicine to manage their migraines, and found it effective, will be taught to do self-acupuncture. This is a feasibility study so the main aim is to test the trial design but the researchers will also explore self-acupuncture's effectiveness, acceptability and safety.Read full original descriptionShow less

A Feasibility Trial of Self-Acupuncture for Patients With Migraines (SAM)

Patients who have had a course of acupuncture at the Royal London Hospital for Integrated Medicine to manage their migraines, and found it effective, will be taught to do self-acupuncture. This is a feasibility study so the main aim is to test the trial design but the researchers will also explore self-acupuncture's effectiveness, acceptability and safety.

Inclusion: Adult patients aged 18 years old and over; Patients with migraines (when topiramate and propranolol are unsuitable); Patients who have been referred to the Royal London Hospital for Integrated Medicine (RLHIM) for a course of at least 6 acupuncture sessions to manage their migraines; Patients who have completed a course of acupuncture for the management of their migraines at RLHIM and self-declare that they benefitted from it; Patients must have completed the course of acupuncture within the last 3 to 24 months.

Exclusion: Patients currently receiving acupuncture; Patients who have previously been taught or have practiced SA; Patients unwilling to participate (for instance due to needle phobia); Patients with severe clotting dysfunction or who bruise spontaneously; Patients unable to complete the questionnaires as judged by the researchers; Patients who are assessed as being unable to do SA (such as if they have poor hand function).

ClinicalTrials.gov NCT06716944